These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17525716)

  • 61. Haptoglobin genotype and its role in diabetic cardiovascular disease.
    Costacou T; Levy AP
    J Cardiovasc Transl Res; 2012 Aug; 5(4):423-35. PubMed ID: 22447230
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Patient selection and vitamin E treatment in diabetes mellitus.
    Goldenstein H; Levy NS; Lipener YT; Levy AP
    Expert Rev Cardiovasc Ther; 2013 Mar; 11(3):319-26. PubMed ID: 23469912
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Distribution of haptoglobin genotypes among persons subjected to chronic occupational irradiation in significant doses].
    Tel'nov VI
    Genetika; 1994 Sep; 30(9):1274-7. PubMed ID: 8001809
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy.
    Dave GS; Kalia K
    Cell Mol Biol (Noisy-le-grand); 2007 May; 53(5):68-78. PubMed ID: 17543235
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study.
    Zhang D; Ma J; Brismar K; Efendic S; Gu HF
    J Diabetes Complications; 2009; 23(4):265-72. PubMed ID: 18599322
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Haptoglobin phenotypes, which one is better and when?
    Zvi B; Levy AP
    Clin Lab; 2006; 52(1-2):29-35. PubMed ID: 16506361
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property.
    Nam SM; Lee MY; Koh JH; Park JH; Shin JY; Shin YG; Koh SB; Lee EY; Chung CH
    Diabetes Res Clin Pract; 2009 Feb; 83(2):176-82. PubMed ID: 19111363
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antioxidant effect of haptoglobin phenotypes against DNA damage induced by hydrogen peroxide in human leukocytes.
    Moreira LR; Miranda-Vilela AL; Silva IC; Akimoto AK; Klautau-Guimarães MN; Grisolia CK
    Genet Mol Res; 2009; 8(1):284-90. PubMed ID: 19291877
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Association between diabetic nephropathy and other diabetic microvascular and macrovascular complications.
    Chandy A; Pawar B; John M; Isaac R
    Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):924-8. PubMed ID: 18974577
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Apolipoprotein E polymorphism and expression in type 2 diabetic patients with nephropathy: clinicopathological correlation.
    Guan J; Zhao HL; Baum L; Sui Y; He L; Wong H; Lai FM; Tong PC; Chan JC
    Nephrol Dial Transplant; 2009 Jun; 24(6):1889-95. PubMed ID: 19218599
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The change of oxidative stress products in diabetes mellitus and diabetic retinopathy.
    Pan HZ; Zhang H; Chang D; Li H; Sui H
    Br J Ophthalmol; 2008 Apr; 92(4):548-51. PubMed ID: 18369071
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A unique tetrameric structure of deer plasma haptoglobin--an evolutionary advantage in the Hp 2-2 phenotype with homogeneous structure.
    Lai IH; Lin KY; Larsson M; Yang MC; Shiau CH; Liao MH; Mao SJ
    FEBS J; 2008 Mar; 275(5):981-93. PubMed ID: 18298795
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Does the Concentration of Oxidative and Inflammatory Biomarkers Differ by Haptoglobin Genotype in Type 1 Diabetes?
    Costacou T; Evans RW; Orchard TJ
    Antioxid Redox Signal; 2015 Dec; 23(18):1439-44. PubMed ID: 26114833
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Methylenetetrahydrofolate reductase and methionine synthase reductase gene polymorphisms and protection from microvascular complications in adolescents with type 1 diabetes.
    Wiltshire EJ; Mohsin F; Chan A; Donaghue KC
    Pediatr Diabetes; 2008 Aug; 9(4 Pt 2):348-53. PubMed ID: 18774994
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Interaction Between the Haptoglobin Genotype and Vitamin E on Cardiovascular Disease in Diabetes.
    Hochberg I; Berinstein EM; Milman U; Shapira C; Levy AP
    Curr Diab Rep; 2017 Jun; 17(6):42. PubMed ID: 28451949
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype.
    Asleh R; Blum S; Kalet-Litman S; Alshiek J; Miller-Lotan R; Asaf R; Rock W; Aviram M; Milman U; Shapira C; Abassi Z; Levy AP
    Diabetes; 2008 Oct; 57(10):2794-800. PubMed ID: 18599520
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Genetic factors for diabetic microvascular complications].
    Yasuda K
    Nihon Rinsho; 2010 Nov; 68 Suppl 9():70-4. PubMed ID: 21661145
    [No Abstract]   [Full Text] [Related]  

  • 78. Haptoglobin Genotype Is a Determinant of Hemoglobin Adducts and Vitamin E Content in HDL.
    Goldenstein H; Levy NS; Ward J; Costacou T; Levy AP
    J Diabetes Res; 2018; 2018():6125420. PubMed ID: 29888289
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Investigation of the distribution of haptoglobin genotypes in human populations].
    Rautian GS; Mironenko VR; Kalabushkin BA
    Genetika; 1988 Dec; 24(12):2226-36. PubMed ID: 3250910
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Building a bridge between clinical and basic research: the phenotypic elements of familial predisposition to type 1 diabetes.
    Matteucci E; Giampietro O
    Curr Med Chem; 2007; 14(5):555-67. PubMed ID: 17346147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.